| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/06/2011 | US8012935 Oligopeptide for blocking cancer |
| 09/06/2011 | US8012933 Use of the cathelicidin LL-37 and derivatives therof for wound healing |
| 09/06/2011 | US8012707 MN gene and protein |
| 09/06/2011 | US8012480 Detection of proteins from circulating neoplastic cells |
| 09/06/2011 | US8012470 Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies |
| 09/06/2011 | US8012469 Universal GM-CSF expressing bystander human K562 cell line |
| 09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
| 09/06/2011 | CA2701704C Process for producing crystal |
| 09/06/2011 | CA2559633C Vaccine compositions obtained from streptomyces |
| 09/06/2011 | CA2502293C Ship 1 modulators |
| 09/06/2011 | CA2498976C Medicinal formulation in particular for treating herniated invertebral discs |
| 09/06/2011 | CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/06/2011 | CA2492130C Inhibitors of cyclin-dependent kinases and their use |
| 09/06/2011 | CA2469275C 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 09/06/2011 | CA2457983C Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide |
| 09/06/2011 | CA2439410C Analogs of thalidomide as potential angiogenesis inhibitors |
| 09/06/2011 | CA2415228C Treatment of bone diseases |
| 09/06/2011 | CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/01/2011 | WO2011106650A2 Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease |
| 09/01/2011 | WO2011106577A2 Method for treating brain cancer |
| 09/01/2011 | WO2011106481A1 Dna dendrimers as thermal ablation devices |
| 09/01/2011 | WO2011106376A2 Use of microvesicles in the treatment of medical conditions |
| 09/01/2011 | WO2011106297A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/01/2011 | WO2011106248A2 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 09/01/2011 | WO2011105963A1 Photosensitizer-containing composition |
| 09/01/2011 | WO2011105573A1 Anti-icam3 antibody and use thereof |
| 09/01/2011 | WO2011105551A1 Method for detection of cancer stem cell, and therapeutic agent or recurrence-preventing agent for cancer |
| 09/01/2011 | WO2011105520A1 Composite body for antigen or drug delivery |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011104680A1 Oxadiazole compounds, their preparation and use |
| 09/01/2011 | WO2011104671A1 Novel water soluble furoxan derivatives having antitumor activity |
| 09/01/2011 | WO2011104631A1 Sn-38 compositions |
| 09/01/2011 | WO2011104558A1 Cancer vaccine |
| 09/01/2011 | WO2011104490A2 Use of essential oil of oregano and of rosewood, or constituents thereof, in the therapeutic treatment of keratoses |
| 09/01/2011 | WO2011104489A2 Use of essential oil of oregano or of rosewood, or constituents thereof, in the cosmetic treatment of keratoses |
| 09/01/2011 | WO2011104409A1 Platinum complexes with trans geometry, comprising a sulphonamide ligand with antitumour activity |
| 09/01/2011 | WO2011104338A1 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104337A1 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | WO2011104334A1 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| 09/01/2011 | WO2011104266A1 Dimeric iap inhibitors |
| 09/01/2011 | WO2011103806A1 Oral microemulsion of elemene |
| 09/01/2011 | WO2011103794A1 Spray for treating diseases caused by human papilloma virus and preparation method thereof |
| 09/01/2011 | WO2011103773A1 Pegylated cyclopamine analogue, preparation method and uses thereof |
| 09/01/2011 | WO2011103702A1 Fully human monoclonal antibody to vegf, preparation method and use thereof |
| 09/01/2011 | WO2011103700A1 Fully humanized anti-her2 antibody, preparation method and use thereof |
| 09/01/2011 | WO2011070440A3 Oncolytic rhabdovirus |
| 09/01/2011 | WO2011043564A3 Composition containing black ginseng extracts for preventing or treating liver cancer |
| 09/01/2011 | WO2011027249A3 Benzimidazole derivatives |
| 09/01/2011 | WO2011020114A3 Methods of treating cancer using tachykinin retargeted endopeptidases |
| 09/01/2011 | WO2010114982A3 Lyophilization cakes of proteasome inhibitors |
| 09/01/2011 | WO2010088842A8 Pharmaceutical compositions containing pyridyl cyanoguanidines, preparation methods and uses thereof |
| 09/01/2011 | US20110213337 Methods for the early diagnosis of ovarian cancer |
| 09/01/2011 | US20110213193 Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier |
| 09/01/2011 | US20110213130 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213019 Compositions and Methods for Treating Cancer, Inhibiting Proliferation, and Inducing Cell Death |
| 09/01/2011 | US20110213015 Oligonucleotidic sequences able to silence the expression of the cyclin d1-trop2 chimera and uses thereof in medical field |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |
| 09/01/2011 | US20110213012 Treatment of Cancers Characterized by Chromosomal Rearrangement of the NUT Gene |
| 09/01/2011 | US20110213006 Compositions and Methods for Treatment of Uncontrolled Cell Growth |
| 09/01/2011 | US20110213003 Substituted hydroxamic acids and uses thereof |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110213001 Pharmaceutical compositions |
| 09/01/2011 | US20110212994 Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders |
| 09/01/2011 | US20110212991 Diagnostic Test for Susceptibility to B-RAF Kinase Inhibitors |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212981 Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and TS Expression |
| 09/01/2011 | US20110212979 Predictive marker for egfr inhibitor treatment |
| 09/01/2011 | US20110212978 Combination of ZD6474 and Pemetrexed |
| 09/01/2011 | US20110212977 P70 s6 kinase inhibitor and mtor inhibitor combination therapy |
| 09/01/2011 | US20110212969 Substituted hydroxamic acids and uses thereof |
| 09/01/2011 | US20110212967 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 09/01/2011 | US20110212965 Inhibitors of Histone Deacetylase |
| 09/01/2011 | US20110212963 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 09/01/2011 | US20110212962 P38 map kinase inhibitors |
| 09/01/2011 | US20110212961 Pyrazole Derivatives as Kinase Inhibitors |
| 09/01/2011 | US20110212958 Fatty acid raloxifene derivatives and their uses |
| 09/01/2011 | US20110212956 Pyrazolopyrimidines for treating CNS disorders |
| 09/01/2011 | US20110212955 Rosamine derivatives as agents for the treatment of cancer |
| 09/01/2011 | US20110212954 Alpha-lipoic acid derivatives and their use in drug preparation |
| 09/01/2011 | US20110212953 Polymorph Form II of Tanaproget |
| 09/01/2011 | US20110212951 Human protein tyrosine phosphatase inhibitors and methods of use |
| 09/01/2011 | US20110212945 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 09/01/2011 | US20110212943 Novel bridged cyclic compounds as histone deacetylase inhibitors |
| 09/01/2011 | US20110212942 Inhibitors of polo-like kinase |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212929 Protein Kinase Inhibitors |
| 09/01/2011 | US20110212923 Phosphate Derivatives of Substituted Benzoxazoles |
| 09/01/2011 | US20110212921 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
| 09/01/2011 | US20110212911 Transcription factor inhibitors and related compositions, formulations and methods |
| 09/01/2011 | US20110212907 Hexadecasaccharides with antithrombotic activity, including a covalent bond and an amino chain |
| 09/01/2011 | US20110212906 C-linked glucuronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and methods of using the same to inhibit neoplastic cell growth |
| 09/01/2011 | US20110212900 Method for prophylactic and/or therapeutic treatment of pain associated with hematopoietic cell transplantation |
| 09/01/2011 | US20110212898 Chimeric peptides for the regulation of gtpases |
| 09/01/2011 | US20110212890 Metastin derivative and use thereof |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212882 Uses of kappa opioid synthetic peptide amides |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212197 Plant Extract and Its Therapeutic Use |